Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05266729

Determine the Dosing Interval and Optimal Dose of AYP-101 for the Reduction of Submental Fat in Chin Area

Moderate or Severe Submental Fullness Clinical Trial

Official title:
A Single Center, Randomized, Placebo Controlled Phase Ⅱ Study to Determine the Dosing Interval and the Optimal Dose of AYP-101 S.C. Injection for the Reduction of Submental Fat

Clinical Trial Summary

To determine the dosing interval, optimal dose, evaluate safety, and efficacy of AYP-101 S.C injection for the reduction of Submental Fat (SMF).

Clinical Trial Description

This study is to determine the dosing interval, optimal dose, evaluate safety and efficacy of AYP-101 S.C injection for the reduction of SMF who wish improvement in the appearance of moderate to severe convexity or fullness associated with SMF in adults. ;

Study Design

Related Conditions & MeSH terms

  • Moderate or Severe Submental Fullness
Clinical Trial Details
NCT number NCT05266729
Study type Interventional
Source AMIpharm Co., Ltd.
Contact
Status Completed
Phase Phase 2
Start date March 2, 2022
Completion date February 20, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT01546142 - Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area Phase 3
Completed NCT03982225 - Evaluate the Efficacy and Safety of Polyene Phosphatidylcholine Injection (AYP-101) for the Reduction of Submental Fat Phase 2
Completed NCT01294644 - Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Phase 3
Completed NCT01542034 - Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area Phase 3
Completed NCT02007434 - Patient Experience Study of Deoxycholic Acid Injection Phase 3
Completed NCT01305577 - Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Phase 3
Completed NCT01032889 - Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study Phase 2
Completed NCT01426373 - Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area Phase 3
Completed NCT00618722 - Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Phase 1/Phase 2
Completed NCT00618618 - Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat Phase 2